Abstract:Objective: Salivary gland epithelial cells (SGECs) are key cellular drivers in the pathogenesis of primary Sjögren's syndrome (SS); however, the mechanisms sustaining SGEC activation in primary SS remain unclear. We undertook this study to determine the role of autophagy in the survival and activation of SGECs in primary SS. Methods: Primary SGECs isolated from the minor SGs of patients with primary SS or sicca syndrome were evaluated by flow cytometry, immunoblotting, and immunofluorescence to assess autophagy (autophagic flux, light chain 3 IIB [LC3-IIB], p62, LC3-IIB+/lysosome-associated membrane protein 1 [LAMP-1] staining), apoptosis (annexin V/propidium iodide [PI], caspase 3), and activation (intercellular adhesion molecule, vascular cell adhesion molecule). Focus score and germinal center presence were assessed in the SGs from the same patients to assess correlation with histologic severity. Human SG (HSG) cells were stimulated in vitro with peripheral blood mononuclear cells (PBMCs) and serum from primary SS patients in the presence or absence of autophagy inhibitors to determine changes in autophagy and epithelial cell activation. Results: SGECs from primary SS patients (n = 24) exhibited increased autophagy (autophagic flux [P = 0.001]; LC3-IIB [P = 0.02]; p62 [P = 0.064]; and as indicated by LC3-IIB/LAMP-1+ staining), increased expression of antiapoptotic molecules (Bcl-2 [P = 0.006]), and reduced apoptosis (annexin V/PI [P = 0.002]; caspase 3 [P = 0.057]), compared to samples from patients with sicca syndrome (n = 16). Autophagy correlated with histologic disease severity. In vitro experiments on HSG cells stimulated with serum and PBMCs from primary SS patients confirmed activation of autophagy and expression of adhesion molecules, which was reverted upon pharmacologic inhibition of autophagy. Conclusion: In primary SS SGECs, inflammation induces autophagy and prosurvival mechanisms, which promote SGEC activation and mirror histologic severity. These findings indicate that autophagy is a central contributor to the pathogenesis of primary SS and a new therapeutic target.

Epigenetics in Primary Sjögren's Syndrome

Biomarkers for Primary Sjögren’s Syndrome

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Abnormal Epigenetic Regulations in the Immunocytes of Sjögren's Syndrome Patients and Therapeutic Potentials

Abnormal Epigenetic Regulations in the Immunocytes of Sjögren’s Syndrome Patients and Therapeutic Potentials

Follicular Helper T Cells and Follicular Regulatory T Cells in the Immunopathology of Primary Sjögren's Syndrome

Genetics and epigenetics of primary Sjögren syndrome: implications for future therapies

From Molecular Mechanism to the Etiology of Sjogren Syndrome

Mechanisms and New Strategies for Primary Sjögren's Syndrome

Maladaptive Autophagy in the Pathogenesis of Autoimmune Epithelitis in Sjögren's Syndrome

Update on the pathophysiology and treatment of primary Sjögren syndrome

Environmental factors in the pathogenesis of primary Sjögren's syndrome

Primary Sjögren's syndrome: new perspectives on salivary gland epithelial cells

Current State of Knowledge on Primary Sjögren’s Syndrome, an Autoimmune Exocrinopathy

Transcriptomic and Network Analysis of Minor Salivary Glands of Patients With Primary Sjögren’s Syndrome

Characterization of Comprehensive Dynamic Epigenetic Changes During Human Primary Sjögren's Syndrome Progression.

Epithelial–immune cell interplay in primary Sjögren syndrome salivary gland pathogenesis

Salivary Gland Pathology in Sjögren's Syndrome

Dysregulation of NF-kB in glandular epithelial cells results in Sjögren’s-like features

Composition and Regulation of Immune Microenvironment of Salivary Gland in Sjögren's Syndrome

Composition and Regulation of the Immune Microenvironment of Salivary Gland in Sjogren's Syndrome